BriaCell Therapeutics to buyback 10% of common shares warrants
- BriaCell Therapeutics (NASDAQ:BCTX) has received Board’s approval to repurchase up to 1,341,515 common shares and 10% of listed warrants.
- The company expects to finalize the terms of buyback by Sept. 14, 2021 to carry out buyback in next 12 months.
- “BriaCell…
